Nrc Health (NRC) EBIT Margin (2010 - 2026)

Nrc Health (NRC) has 17 years of EBIT Margin data on file, last reported at 16.0% in Q1 2026.

• For the quarter ending Q1 2026, EBIT Margin fell 958.0% year-over-year to 16.0%; the trailing twelve-month figure through Mar 2026 stood at 14.11% (down 1067.0% YoY), and the FY2025 full-year result was 16.44%, down 816.0% from the prior year.
• EBIT Margin improved to 16.0% in Q1 2026, from 13.27% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 32.09% in Q4 2022 to a low of 4.67% in Q2 2025.
• A 5-year average of 24.16% and a median of 25.58% in 2025 frame the typical range for EBIT Margin.
• Peak annual rise in EBIT Margin reached 78 bps in 2025, while the deepest fall reached 2065 bps in 2025.
• Tracing NRC's EBIT Margin over 5 years: stood at 32.09% in 2022, then slipped by 4 bps to 30.81% in 2023, then decreased by 16 bps to 25.98% in 2024, then tumbled by 49 bps to 13.27% in 2025, then advanced by 21 bps to 16.0% in 2026.
• Business Quant data shows NRC's EBIT Margin at 16.0% in Q1 2026, 13.27% in Q4 2025, and 22.36% in Q3 2025.